GNCA

Genocea Biosciences (GNCA)

Genocea Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNCA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/06/14	06 : 22	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/13	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/13	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/10	05 : 17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/10	05 : 14	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/08	19 : 02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/08	19 : 02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 00	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/06	19 : 00	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/04	05 : 19	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/04	05 : 17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/04	05 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/06/04	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/28	05 : 59	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/27	07 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/27	07 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/27	07 : 30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/27	07 : 27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/27	07 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc
2022/05/27	07 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GNCA	Genocea Biosciences Inc